Did you know that targeting the OX40-OX40 ligand (OX40-OX40L) pathway may lead to long-term remission in atopic dermatitis (AD)?

Credit available for this activity expires: 6/26/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001214?ecd=bdc_podcast_libsyn_mscpedu

How would you manage a patient with metabolic syndrome and metabolic dysfunction-associated steatohepatitis?

Credit available for this activity expires:  6/26/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001260?ecd=bdc_podcast_libsyn_mscpedu

Get the latest data from ASCO 2024 about anti-HER2 therapies in biliary tract cancer.

Credit available for this activity expires: 6/25/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001250?ecd=bdc_podcast_libsyn_mscpedu

Are you aware of patients’ perceptions and wishes about diagnosis and management of transthyretin amyloid cardiomyopathy (ATTR-CM)?

Credit available for this activity expires: 6/18/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001176?ecd=bdc_podcast_libsyn_mscpedu

How much do you know about new acid suppressive treatments for gastroesophageal reflux disease (GERD)?

Credit available for this activity expires: 6/12/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001195?ecd=bdc_podcast_libsyn_mscpedu

Hear from 3 experts as they discuss the latest clinical knowledge on the management of gastroesophageal reflux disease (GERD) and erosive esophagitis.

Credit available for this activity expires: 6/11/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001184?ecd=bdc_podcast_libsyn_mscpedu

Join the experts for an in-depth discussion on the latest developments in targeted therapies for relapsed/refractory chronic lymphocytic leukemia (R/R CLL), and a look ahead to the upcoming EHA2024 conference.    Credit available for this activity expires: 6/6/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001161?ecd=bdc_podcast_libsyn_mscpedu

Listen to the experts discuss treatment options for relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL) and R/R mantle cell lymphoma (MCL) in 4 unique patient cases.    Credit available for this activity expires: 06/07/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000852?ecd=bdc_podcast_libsyn_mscpedu

Do you know how to have a heads-up conversation about biosimilars? 

Credit available for this activity expires: 6/6/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001162?ecd=bdc_podcast_libsyn_mscpedu

What are the main indicators that a patient with multiple sclerosis (MS) can be switched to a biosimilar?    Credit available for this activity expires: 5/31/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000864?ecd=bdc_podcast_libsyn_mscpedu